Title : p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes.

Pub. Date : 2008 Jul

PMID : 18325917






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes. Anthracyclines tumor protein p53 Homo sapiens
2 BACKGROUND: We hypothesized that, among molecular subclasses of breast cancer, p53 status may have a differential predictive value for the efficacy of anthracyclines/alkylating agents-based regimen. Anthracyclines tumor protein p53 Homo sapiens
3 CONCLUSION: p53 status may have a different predictive value for efficacy of anthracycline/alkylating agents-based regimen in each molecular subclass, a result which may explain the different results reported in literature. Anthracyclines tumor protein p53 Homo sapiens